Year archive

Immunotech Biopharm Ltd — 2025 filings

All 46 regulatory filings released by Immunotech Biopharm Ltd (6978) in 2025, sourced directly from the official regulator.

46 Filings

2025 Period

2025 filings (46)

Filing	Released	Lang
DISCLOSEABLE TRANSACTION SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS Regulatory Filings	2025-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2025 Regulatory Filings	2025-12-03	English
Next Day Disclosure Return Share Issue/Capital Change	2025-11-13	English
RESULTS OF RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE AND ADJUSTMENTS TO THE CONVERSION PRICES OF THE CONVERTIBLE BONDS AND THE EXERCI Capital/Financing Update	2025-11-12	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025 Regulatory Filings	2025-11-04	English
CHANGE OF NON-EXECUTIVE DIRECTOR AND MEMBER OF THE AUDIT COMMITTEE Board/Management Information	2025-10-16	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2025-10-16	English
Documents on Display Regulatory Filings	2025-10-13	English
EXCESS APPLICATION FORM Share Issue/Capital Change	2025-10-13	English
RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE Share Issue/Capital Change	2025-10-13	English
PROVISIONAL ALLOTMENT LETTER Share Issue/Capital Change	2025-10-13	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025 Share Issue/Capital Change	2025-10-03	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-23	English
EXCHANGE NOTICE - RESUMPTION OF TRADING Regulatory Filings	2025-09-22	English
(1) PROPOSED RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE (2) RESUMPTION OF TRADING Share Issue/Capital Change	2025-09-19	English
TRADING HALT Regulatory Filings	2025-09-19	English
EXCHANGE NOTICE - TRADING HALT Regulatory Filings	2025-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2025 Share Issue/Capital Change	2025-09-02	English
ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H2 2025	2025-08-20	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025 Regulatory Filings	2025-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025 Regulatory Filings	2025-07-03	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-06-26	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE Governance Information	2025-06-26	English
APPOINTMENT OF DIRECTORS Board/Management Information	2025-06-26	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-06-25	English
SUPPLEMENTAL ANNOUNCEMENT RESIGNATION OF EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHIEF TECHNOLOGY OFFICER Board/Management Information	2025-06-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Share Issue/Capital Change	2025-06-03	English
RESIGNATION OF EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHIEF TECHNOLOGY OFFICER Board/Management Information	2025-05-30	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Share Issue/Capital Change	2025-05-06	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 23 MAY 2025 Proxy Solicitation & Information Statement	2025-04-29	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-29	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-29	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-29	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2025-04-25	English
CHANGE OF NON-EXECUTIVE DIRECTOR AND MEMBER OF THE AUDIT COMMITTEE Board/Management Information	2025-04-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-02	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 Regulatory Filings	2025-03-31	English
VOLUNTARY ANNOUNCEMENT CONDITIONAL NEW DRUG APPLICATION OF EAL ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2025-03-31	English
POSTPONEMENT OF BOARD MEETING Regulatory Filings	2025-03-24	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Share Issue/Capital Change	2025-03-03	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE - RECENT DEVELOPMENT OF EAL Regulatory Filings	2025-02-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-02	English